Breaking News Instant updates and real-time market news.

AMD

AMD

$20.41

0.49 (2.46%)

, AMZN

Amazon.com

$1,646.45

18.75 (1.15%)

12:16
11/06/18
11/06
12:16
11/06/18
12:16

AMD announces EPYC processors now available on Amazon Web Services

AMD

AMD

$20.41

0.49 (2.46%)

AMZN

Amazon.com

$1,646.45

18.75 (1.15%)

  • 06

    Nov

  • 06

    Nov

  • 09

    Nov

  • 14

    Nov

  • 26

    Nov

  • 28

    Nov

  • 04

    Dec

  • 06

    Dec

AMD AMD
$20.41

0.49 (2.46%)

10/25/18
NORL
10/25/18
UPGRADE
Target $26
NORL
Outperform
Follow-up: AMD upgraded to Outperform, selloff 'overdone,' says Northland
As previously reported, Northland upgraded AMD to Outperform from Market Perform and maintained a $26 price target. Analyst Auguste Richard said the selloff in shares is "overdone" and sees catalysts from consensus estimates reflecting headwinds from the Semicustom and Crypto implosion, November 6 analyst meeting, launch of 7nm data center GPU in Q4 and 7nm Server CPU likely 1H 2019, flexible production using 2 foundries and multi chip packaging, and reduced CPU output upside in Q4.
10/26/18
OPCO
10/26/18
NO CHANGE
OPCO
Perform
Intel demise rumors 'greatly exaggerated,' says Oppenheimer
Oppenheimer analyst Rick Schafer maintained a Perform rating on Intel (INTC) following the company's "solid" beat/raise results. In a research note to investors titled "Demise Rumors Greatly Exaggerated," Schafer says AMD's (AMD) 2nd gen 7nm Epyc2 server processor is expected to garner share in 2019, though he expects gains could fall short of bullish 10%-type expectations, but gross margins as well as share headwinds and limited growth and free cash flow leverage keep him sidelined here.
10/30/18
COWN
10/30/18
NO CHANGE
Target $26
COWN
Outperform
AMD price target lowered to $26 from $33 at Cowen
Cowen analyst Matthew Ramsay lowered his price target on AMD to $26 from $33 following a "noisy" Q3 and "disappointing" Q4 guidance. The analyst met with management and reexamined his model and maintained that the company's core franchise performed well. He said his long-term thesis of Datacenter and PC share gains remains fully intact, which will drive strong gross margin expansion and earnings growth. Ramsay maintained his Outperform rating on AMD shares.
11/05/18
SBSH
11/05/18
NO CHANGE
SBSH
Citi recommends buying Semis that have lowered guidance
Semiconductors are in the "bottom-forming" process as estimates are declining in line with previous corrections and most of the downside to estimates should be out by January barring a recession, Citi analyst Christopher Danely tells investors in a research note. The analyst recommends building positions in companies that have lowered guidance such as Buy-rated Texas Instruments (TXN), which is his top pick. He also has Buy ratings on Microchip (MCHP) and ON Semiconductor (ON). Danely's lone Sell rated name is AMD (AMD).
AMZN Amazon.com
$1,646.45

18.75 (1.15%)

11/01/18
DAIW
11/01/18
UPGRADE
Target $2000
DAIW
Buy
Daiwa upgrades Amazon to Buy from Outperform after selloff
Daiwa analyst Satoshi Tanaka upgraded Amazon.com to Buy from Outperform with an unchanged price target of $2,000. The stock in midday trading is up 2%, or $35.06, to $1,633.07. Despite "short-term uncertainties" following last week's Q3 sales miss, Amazon's long-term outlook is intact, Tanaka tells investors in a research note. The analyst now sees 30% upside potential following the recent selloff in the shares. He forecasts 31% sales growth year-over-year and 205% operating income growth for Amazon in fiscal 2018.
11/02/18
SPHN
11/02/18
DOWNGRADE
Target $26
SPHN
Underweight
Synchrony downgraded to Underweight from Equal Weight at Stephens
Stephens analyst Vincent Caintic downgraded Synchrony (SYF) to Underweight from Equal Weight, citing the negative implications he sees from the lawsuit against the company from Walmart (WMT). Beyond the potential for over $800M in damages, the suit implies the Sam's Club account is lost, the Amazon (AMZN) account is "in jeopardy," and other retailers can be expected to "take a hard look" at their own relationships with Synchrony, Caintic believes. He lowered his price target on Synchrony shares to $26 from $32.
11/05/18
BARD
11/05/18
NO CHANGE
Target $2100
BARD
Outperform
Amazon Q4 profit likely to be minimally impacted by free shipping, says Baird
Baird analyst Colin Sebastian assumes Amazon's newly-announced free shipping promotions will drive somewhat higher order volume with a slight increase in average order value, estimating that Amazon will generate roughly $500M in incremental revenues and an equivalent amount of incremental shipping costs due to the deals. However, he also assume that the free shipping promotion is worth roughly $100M in holiday ads or other promotional spending. In total, he sees the net impact of this free shipping promotion to be a $300M drag on operating income, or a 5-6% impact overall to Amazon's Q4 operating profit. The analyst, who also thinks the free shipping is presumably already reflected in the company's Q4 guidance, keeps an Outperform rating and $2,100 price target on Amazon shares.
11/06/18
LEHM
11/06/18
DOWNGRADE
Target $18
LEHM
Underweight
Barclays downgrades New York Times to Underweight on valuation
Barclays analyst Kannan Venkateshwar downgraded New York Times (NYT) to Underweight from Equal Weight and lowered his price target for the shares to $18 from $20. The stock is up 50% this year, right between Amazon's (AMZN) 40% rally and Netflix's (NFLX) 64%, Venkateshwar tells investors in a research note. New York Times investors appear to have transitioned to a valuation framework based on digital net adds rather than earnings, says the analyst. However, he believes this valuation transition "is too premature and could force suboptimal choices on management." Venkateshwar says the valuation is "ahead of the story."

TODAY'S FREE FLY STORIES

CPTA

Capitala Finance

$8.06

0.03 (0.37%)

08:11
11/19/18
11/19
08:11
11/19/18
08:11
Hot Stocks
Capitala Group invests in Visible Body »

Capitala Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$28.13

-0.05 (-0.18%)

08:11
11/19/18
11/19
08:11
11/19/18
08:11
Hot Stocks
eBay announces Black Friday, Cyber Monday deals »

eBay is kicking off eight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

RGLS

Regulus

$1.42

0.1 (7.58%)

08:09
11/19/18
11/19
08:09
11/19/18
08:09
Hot Stocks
Regulus presents new data on anti-miR candidate for treatment of GBM »

Regulus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVZMY

Novozymes

$0.00

(0.00%)

08:09
11/19/18
11/19
08:09
11/19/18
08:09
Conference/Events
Novozymes to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCLI

BrainStorm

$3.17

0.02 (0.63%)

08:08
11/19/18
11/19
08:08
11/19/18
08:08
Hot Stocks
BrainStorm submits IND to FDA for NurOwn »

BrainStorm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BE

Bloom Energy

$16.04

0.56 (3.62%)

08:08
11/19/18
11/19
08:08
11/19/18
08:08
Hot Stocks
Bloom Energy enters strategic partnership with SK E&C »

SK Group and Bloom Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

DRRX

Durect

$0.91

-0.0094 (-1.02%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Hot Stocks
Durect amends ongoing Phase 2a trial of DUR-928 »

Durect announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CACI

CACI

$180.35

-0.03 (-0.02%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Hot Stocks
CACI awarded $413M contract for U.S. Army communications systems support »

CACI International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLND

Talend

$37.44

-1.13 (-2.93%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Recommendations
Talend analyst commentary  »

Talend price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

MGTA

Magenta Therapeutics

$7.50

0.4 (5.63%)

08:06
11/19/18
11/19
08:06
11/19/18
08:06
Hot Stocks
Magenta Therapeutics names Jason Ryan as Chief Operating and Financial Officer »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

NERV

Minerva

$8.41

0.11 (1.33%)

08:06
11/19/18
11/19
08:06
11/19/18
08:06
Hot Stocks
Minerva announces results from roluperidone study »

Minerva announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BKI

Black Knight

$49.77

0.87 (1.78%)

, DNB

Dun & Bradstreet

$142.27

0.11 (0.08%)

08:05
11/19/18
11/19
08:05
11/19/18
08:05
Hot Stocks
Black Knight board approves $375M investment in Dun & Bradstreet »

Black Knight (BKI)…

BKI

Black Knight

$49.77

0.87 (1.78%)

DNB

Dun & Bradstreet

$142.27

0.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 03

    Dec

CMP

Compass Minerals

$52.49

0.98 (1.90%)

08:04
11/19/18
11/19
08:04
11/19/18
08:04
Hot Stocks
Compass Minerals CEO to step down, Dick Grant named interim CEO »

Compass Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LANC

Lancaster Colony

$182.53

-0.21 (-0.11%)

08:03
11/19/18
11/19
08:03
11/19/18
08:03
Hot Stocks
Lancaster Colony acquires assets of Omni Baking Company for $25M »

Lancaster Colony…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TENX

Tenax Therapeutics

$3.80

(0.00%)

08:03
11/19/18
11/19
08:03
11/19/18
08:03
Hot Stocks
Tenax activates first clinical research site for Phase 2 trial of levosimendan »

Tenax Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLDB

Solid Biosciences

$33.82

2.81 (9.06%)

, SRPT

Sarepta

$119.02

0.14 (0.12%)

08:02
11/19/18
11/19
08:02
11/19/18
08:02
Conference/Events
Morgan Stanley to hold a bus trip »

Biotech Boston Bus Trip…

SLDB

Solid Biosciences

$33.82

2.81 (9.06%)

SRPT

Sarepta

$119.02

0.14 (0.12%)

NTGN

Neon Therapeutics

$6.98

-0.1 (-1.41%)

EDIT

Editas Medicine

$29.00

0.92 (3.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NEE

NextEra Energy

$180.41

1.27 (0.71%)

08:02
11/19/18
11/19
08:02
11/19/18
08:02
Hot Stocks
NextEra Energy Transmission to acquire Trans Bay Cable for approximately $1B »

NextEra Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

KMB

Kimberly-Clark

$111.22

0.43 (0.39%)

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Periodicals
Kimberly-Clark won't sell European tissue business with bids too low, FT says »

Kimberly-Clark will call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Conference/Events
Bernstein to hold a symposium »

5th Annual Asset…

NEE

NextEra Energy

$180.41

1.27 (0.71%)

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Hot Stocks
Breaking Hot Stocks news story on NextEra Energy »

NextEra Energy to acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Conference/Events
Wedbush to hold a tour »

2018 Holiday Shopping…

HP

Helmerich & Payne

$62.59

2.54 (4.23%)

08:00
11/19/18
11/19
08:00
11/19/18
08:00
Upgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SASR

Sandy Spring Bancorp

07:57
11/19/18
11/19
07:57
11/19/18
07:57
Upgrade
Sandy Spring Bancorp rating change  »

Sandy Spring Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBH

Sally Beauty

$20.61

-0.425 (-2.02%)

07:57
11/19/18
11/19
07:57
11/19/18
07:57
Recommendations
Sally Beauty analyst commentary  »

Sally Beauty price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHLD

National Holdings Corp

$2.96

(0.00%)

07:57
11/19/18
11/19
07:57
11/19/18
07:57
Hot Stocks
Breaking Hot Stocks news story on National Holdings Corp »

National Holdings Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.